TrueMark Investments’s Novo Nordisk NVO Stock Holding History

TrueMark Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-193,853	Closed	-$9.86M	–	238
2025 Q4	$9.86M	Buy	193,853 +33,437	+21%	+$1.71M	1.88%	10
2025 Q3	$8.9M	Buy	160,416 +124,265	+344%	+$7.27M	1.55%	13
2025 Q2	$2.5M	Buy	36,151 +24,839	+220%	+$1.69M	0.54%	74
2025 Q1	$786K	Sell	11,312 -844	-7%	-$69.7K	0.21%	99
2024 Q4	$1.05M	Sell	12,156 -1,002	-8%	-$108K	0.33%	89
2024 Q3	$1.57M	Sell	13,158 -289	-2%	-$38.5K	0.5%	75
2024 Q2	$1.92M	Buy	+13,447	New	+$1.78M	0.66%	56

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

TrueMark Investments's NVO Position: Q1 2026 in Review

TrueMark Investments sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 193,853 shares — an estimated $9.86M sold.

TrueMark Investments first reported a position in NVO in Q2 2024 and held it in 7 quarters. The position peaked at $9.86M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

TrueMark Investments reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
TrueMark Investments sold 193,853 Novo Nordisk shares in Q1 2026, an estimated $9.86M.
TrueMark Investments first reported a position in Novo Nordisk in Q2 2024 and held it in 7 quarters.
TrueMark Investments's Novo Nordisk position peaked at $9.86M in Q4 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.